Evidence map›Paper›PMID 37317288›Full record

ArticleMicroorganisms2023

Carbapenem-Resistant

Amalia Papanikolopoulou, Panagiotis Gargalianos-Kakolyris, Athina Stoupis, Nikos Moussas, Anastasia Pangalis, Kalliopi Theodoridou, Genovefa Chronopoulou, Nikos Pantazis, Maria Kantzanou, Helena C Maltezou and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Amalia PapanikolopoulouClinical Pharmacology Department, Athens Medical Center, 5-7 Distomou Str., 15125 Marousi, Greece.
Panagiotis Gargalianos-KakolyrisClinical Infectious Diseases Department, Athens Medical Center, 1 Delfon Str., 15125 Marousi, Greece.
Athina StoupisClinical Infectious Diseases Department, Athens Medical Center, 1 Delfon Str., 15125 Marousi, Greece.
Nikos MoussasClinical Infectious Diseases Department, Athens Medical Center, 1 Delfon Str., 15125 Marousi, Greece.
Anastasia PangalisBiopathology Department, Athens Medical Center, 5-7 Distomou Str., 15125 Marousi, Greece.
Kalliopi TheodoridouDepartment of Microbiology, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Str., 11527 Athens, Greece.
Genovefa ChronopoulouBiopathology Department, Athens Medical Center, 5-7 Distomou Str., 15125 Marousi, Greece.
Nikos PantazisDepartment of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, 75 Mikras Asias Str., 11527 Athens, Greece.ORCID 0000-0002-4196-5066
Maria KantzanouDepartment of Microbiology, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Str., 11527 Athens, Greece.
Helena C MaltezouDirectorate of Research, Studies and Documentation, National Public Health Organization, 3-5 Agrafon Str., 15123 Athens, Greece.ORCID 0000-0003-0264-3547
Athanasios TsakrisDepartment of Microbiology, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Str., 11527 Athens, Greece.ORCID 0000-0003-0656-4715
Athens Medical Center · GRNational and Kapodistrian University of Athens · GRNational Public Health Organization · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarbapenem-resistant

methodsWe prospectively recorded the incidence of CRPA bacteremia, antibiotic consumption, use of hand-hygiene solutions, and isolation rates of multidrug-resistant (MDR) carrier patients.

findingsThe consumption of colistin, aminoglycosides, and third-generation cephalosporins decreased significantly in the total hospital and its divisions (

conclusionIn our hospital, multimodal infection control interventions resulted in a significant reduction of CRPA bacteremia, mostly due to the reduction of all classes of antibiotics.

Indexed as

antibiotic consumptioncarbapenem-resistant Pseudomonas aeruginosa bacteremiahospitalinfection control interventions

Identifiers

PMID37317288
PMCPMC10220838
OpenAlexW4377103911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.